146 related articles for article (PubMed ID: 10882417)
1. Novel molecular mechanisms of dendritic cell-induced T cell activation.
Woodhead VE; Stonehouse TJ; Binks MH; Speidel K; Fox DA; Gaya A; Hardie D; Henniker AJ; Horejsi V; Sagawa K; Skubitz KM; Taskov H; Todd RF; van Agthoven A; Katz DR; Chain BM
Int Immunol; 2000 Jul; 12(7):1051-61. PubMed ID: 10882417
[TBL] [Abstract][Full Text] [Related]
2. From sentinel to messenger: an extended phenotypic analysis of the monocyte to dendritic cell transition.
Woodhead VE; Binks MH; Chain BM; Katz DR
Immunology; 1998 Aug; 94(4):552-9. PubMed ID: 9767444
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of U937-dependent T-cell co-stimulation.
Stonehouse TJ; Woodhead VE; Herridge PS; Ashrafian H; George M; Chain BM; Katz DR
Immunology; 1999 Jan; 96(1):35-47. PubMed ID: 10233676
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes.
Rowan WC; Hale G; Tite JP; Brett SJ
Int Immunol; 1995 Jan; 7(1):69-77. PubMed ID: 7718516
[TBL] [Abstract][Full Text] [Related]
5. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
6. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of antigen-independent and antigen-dependent interaction of dendritic cells with CD4+ T cells.
Hauss P; Selz F; Cavazzana-Calvo M; Fischer A
Eur J Immunol; 1995 Aug; 25(8):2285-94. PubMed ID: 7545116
[TBL] [Abstract][Full Text] [Related]
8. Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells.
Fagnoni FF; Takamizawa M; Godfrey WR; Rivas A; Azuma M; Okumura K; Engleman EG
Immunology; 1995 Jul; 85(3):467-74. PubMed ID: 7558137
[TBL] [Abstract][Full Text] [Related]
9. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
[TBL] [Abstract][Full Text] [Related]
10. Anti-leucocyte common (CD45) antibodies inhibit dendritic cell stimulation of CD4 and CD8 T-lymphocyte proliferation.
Prickett TC; Hart DN
Immunology; 1990 Feb; 69(2):250-6. PubMed ID: 1968425
[TBL] [Abstract][Full Text] [Related]
11. Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells.
Semnani RT; Nutman TB; Hochman P; Shaw S; van Seventer GA
J Exp Med; 1994 Dec; 180(6):2125-35. PubMed ID: 7525848
[TBL] [Abstract][Full Text] [Related]
12. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
Tohma S; Hirohata S; Lipsky PE
J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
[TBL] [Abstract][Full Text] [Related]
13. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
Hirokawa M; Gray JD; Takahashi T; Horwitz DA
J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
[TBL] [Abstract][Full Text] [Related]
14. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
Young JW; Koulova L; Soergel SA; Clark EA; Steinman RM; Dupont B
J Clin Invest; 1992 Jul; 90(1):229-37. PubMed ID: 1378854
[TBL] [Abstract][Full Text] [Related]
15. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step.
Morel AS; Quaratino S; Douek DC; Londei M
Eur J Immunol; 1997 Jan; 27(1):26-34. PubMed ID: 9021994
[TBL] [Abstract][Full Text] [Related]
16. Synovial fluid transforming growth factor beta inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis.
Summers KL; O'Donnell JL; Heiser A; Highton J; Hart DN
Arthritis Rheum; 1999 Mar; 42(3):507-18. PubMed ID: 10088774
[TBL] [Abstract][Full Text] [Related]
17. Induction of tolerance by IL-10-treated dendritic cells.
Steinbrink K; Wölfl M; Jonuleit H; Knop J; Enk AH
J Immunol; 1997 Nov; 159(10):4772-80. PubMed ID: 9366401
[TBL] [Abstract][Full Text] [Related]
18. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway.
McLellan AD; Sorg RV; Williams LA; Hart DN
Eur J Immunol; 1996 Jun; 26(6):1204-10. PubMed ID: 8647193
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium bovis bacillus Calmette-Guérin-infected dendritic cells potently activate autologous T cells via a B7 and interleukin-12-dependent mechanism.
Cheadle EJ; Selby PJ; Jackson AM
Immunology; 2003 Jan; 108(1):79-88. PubMed ID: 12519306
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells.
Caux C; Massacrier C; Vanbervliet B; Barthelemy C; Liu YJ; Banchereau J
Int Immunol; 1994 Aug; 6(8):1177-85. PubMed ID: 7526890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
